U.K.-based AI health services provider Babylon Health announced last week that it has successfully closed its $550 million Series C funding round, placing the company’s valuation at over $2 billion. According to the company, this marks the largest-ever fundraise for a digital health delivery company in either the United States or Europe. Babylon Health plans to use the new capital to expand to the U.S. and Asia and fund its R&D aimed at the diagnosis of serious, chronic conditions...
Sorry, you need to subscribe to read this article.
If you would like to access this article, please subscribe below.
Premium subscribers receive complete access to our site content which includes market research and insights as well as coverage of the most important news, issues and events related to the healthcare technology industry.